14-75963357-ACC-ACCC
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_003239.5(TGFB3):c.884dupG(p.Gln296SerfsTer28) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_003239.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- cranioectodermal dysplasia 3Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- short-rib thoracic dysplasia 18 with polydactylyInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- cranioectodermal dysplasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- ciliopathyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
- retinitis pigmentosa 81Inheritance: AR, Unknown Classification: LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TGFB3 | NM_003239.5 | c.884dupG | p.Gln296SerfsTer28 | frameshift_variant | Exon 5 of 7 | ENST00000238682.8 | NP_003230.1 | |
| TGFB3 | NM_001329939.2 | c.884dupG | p.Gln296SerfsTer28 | frameshift_variant | Exon 6 of 8 | NP_001316868.1 | ||
| TGFB3 | NM_001329938.2 | c.884dupG | p.Gln296SerfsTer48 | frameshift_variant | Exon 5 of 5 | NP_001316867.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
The c.884dupG variant, located in coding exon 5 of the TGFB3 gene, results from a duplication of G at nucleotide position 884, causing a translational frameshift with a predicted alternate stop codon (p.Q296Sfs*28). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). While loss of function has not yet been clearly established as a mechanism of disease for TGFB3, alterations resulting in haploinsufficiency have been reported in patients with features consistent with manifestations of Loeys-Dietz syndrome (Schepers D et al. Hum Mutat. 2018;39(5):621-634; Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -
Rienhoff syndrome Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gln296Serfs*28) in the TGFB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TGFB3 are known to be pathogenic (PMID: 25835445, 26188975). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TGFB3-related conditions. ClinVar contains an entry for this variant (Variation ID: 1764874). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at